Olumiant® (Baricitinib)
La información es proporcionada en respuesta a su solicitud, y puede contener datos relacionados a dosis, usos, formulaciones y poblaciones diferentes a la Información para Prescribir del producto. Consulte la Información para Prescribir en la liga que aparece arriba.
Description of Baricitinib Tablet
Each tablet has a recessed area on both sides of the tablet surface to facilitate its use.1
Baricitinib 2-mg tablets are light pink in color and oblong in shape with a “Lilly” designation on one side and a “2” designation on the other side of the tablet surface.1
Baricitinib 4-mg tablets are medium pink in color and round in shape with a “Lilly” designation on one side and a “4” designation on the other side of the tablet surface.1
Description of Baricitinib Packaging
Baricitinib tablets are available in
14, 28, 35, 56, 84, and 98 film-coated tablets in plastic film blisters sealed with an aluminum foil, and
28 and 84 film-coated tablets in aluminum perforated unit dose blisters.2
1. Data on file, Eli Lilly and Company and/or one of its subsidiaries.
2. Olumiant [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.
Fecha de la última revisión: 2019 M05 17
Correo electrónico: infomed@lilly.com